Expert view: IVD Market in LAMEA still promises to grow by 4.7% CAGR

IVD Market

IVD Market in LAMEA

The infectious diseases segment was the major shareholder in the LAMEA IVD based application market in 2018.

LAMEA IVD Market by Product Type (Reagents, Instruments, and Software & Services), By Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry)”
— Allied Market Research

NE WIN SIVERS DRIVE, PORTLAND, UNITED STATES, January 13, 2022 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, LAMEA IVD Market by Product Type, Techniques, Application, and End Users: Opportunity Analysis and Industry Forecast, 2017-2023, the LAMEA IVD market was valued at $7,413 million in 2016, and is projected to reach at $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016.

In vitro diagnostics (IVD) are medical devices and reagents used for examination of the body samples such as blood, tissue, and body fluids to detect diseases, disorders, and infections and identify suitable medical treatment. Rise in incidences of chronic and infectious diseases, constant technological developments to improve efficacy of IVD and increase in government healthcare expenditure in LAMEA region drive the market growth. However, stringent government regulations related to the safety and efficacy of the IVD and unfavorable reimbursement policies are expected to restrain the market growth during the forecast period. Ongoing R&D associated with the IVD and increased disposable income of consumers provides huge growth potential for IVD market.

(๐—” ๐—ฃ๐——๐—™ | ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ข๐—ณ ๐—ง๐—ต๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—œ๐˜€ ๐—”๐˜ƒ๐—ฎ๐—ถ๐—น๐—ฎ๐—ฏ๐—น๐—ฒ ๐—œ๐—บ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฎ๐˜๐—ฒ๐—น๐˜† ๐—จ๐—ฝ๐—ผ๐—ป ๐—ฅ๐—ฒ๐—พ๐˜‚๐—ฒ๐˜€๐˜) ๐—ฎ๐˜: https://www.alliedmarketresearch.com/request-sample/4137

๐—–๐—ผ๐˜ƒ๐—ถ๐—ฑ-๐Ÿญ๐Ÿต ๐—ฆ๐—ฐ๐—ฒ๐—ป๐—ฎ๐—ฟ๐—ถ๐—ผ:

1) The COVID-19 impact on the LAMEA IVD Market is unpredictable and is expected to remain in force till the fourth quarter of 2021.

2) The COVID-19 outbreak forced governments across the globe to implement strict lockdowns and banned import-export of nonessential items for most of 2021. This led to sudden fall in the availability of important raw materials.

3) Moreover, nationwide lockdowns forced manufacturing facilities to partially or completely shut their operations.

4) Adverse impacts of the COVID-19 pandemic have resulted in delays in activities and initiatives regarding development of reliable and innovative drone analytics systems globally.

๐—š๐—ฒ๐˜ ๐——๐—ฒ๐˜๐—ฎ๐—ถ๐—น๐—ฒ๐—ฑ ๐—–๐—ผ๐˜ƒ๐—ถ๐—ฑ-๐Ÿญ๐Ÿต ๐—œ๐—บ๐—ฝ๐—ฎ๐—ฐ๐˜ ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€ ๐—ฎ๐˜- https://www.alliedmarketresearch.com/request-for-customization/4137?reqfor=covid

Based on product type, the reagents segment held the highest market share in 2016, owing to the recent introduction of new novel reagents in the market that are more effective.

Based on application, the infectious diseases segment contributed the highest market share in 2016, owing to the increase in prevalence of infectious diseases such as HIV, tuberculosis, and others.

Based on end users, the standalone laboratory segment captured the highest market share in 2016, mainly due to increase in outsourcing of diagnostic test by hospitals.

๐—ž๐—ฒ๐˜† ๐—•๐—ฒ๐—ป๐—ฒ๐—ณ๐—ถ๐˜๐˜€ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐˜๐—ฎ๐—ธ๐—ฒ๐—ต๐—ผ๐—น๐—ฑ๐—ฒ๐—ฟ๐˜€:

โ€ขThis report entails a detailed quantitative analysis along with the current global LAMEA IVD Market trends from 2018 to 2025 to identify the prevailing opportunities along with the strategic assessment.

โ€ขThe LAMEA IVD Market forecast is studied from 2018 to 2025.

โ€ขThe LAMEA IVD Market size and estimations are based on a comprehensive analysis of key developments in the endoscopic retrograde cholangiopancreatography industry.

โ€ขA qualitative analysis based on innovative products facilitates strategic business planning.

โ€ขThe development strategies adopted by the key market players are enlisted to understand the competitive scenario of the LAMEA IVD Market.

๐—Ÿ๐—ถ๐˜€๐˜ ๐—ผ๐—ณ ๐—ž๐—ฒ๐˜† ๐—ฃ๐—น๐—ฎ๐˜†๐—ฒ๐—ฟ๐˜€ ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ถ๐—น๐—ฒ๐—ฑ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:

Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson among others.

๐—ง๐—ผ ๐—š๐—ฒ๐˜ ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜‚๐—ป๐˜, ๐— ๐—ฎ๐—ธ๐—ฒ ๐—ฃ๐˜‚๐—ฟ๐—ฐ๐—ต๐—ฎ๐˜€๐—ฒ ๐—œ๐—ป๐—พ๐˜‚๐—ถ๐—ฟ๐˜† ๐—ฎ๐˜- https://www.alliedmarketresearch.com/purchase-enquiry/4137

๐—™๐—ฟ๐—ฒ๐—พ๐˜‚๐—ฒ๐—ป๐˜๐—น๐˜† ๐—”๐˜€๐—ธ๐—ฒ๐—ฑ ๐—ค๐˜‚๐—ฒ๐˜€๐˜๐—ถ๐—ผ๐—ป๐˜€?

Q1. What are the leading market players active in the LAMEA IVD Market?
Q2. What current trends will influence the market in the next few years?
Q3. What are the driving factors, restraints, and opportunities in the market?
Q4. What are the projections for the future that would help in taking further strategic steps?

๐—”๐—ฉ๐—˜๐—ก๐—จ๐—˜- ๐—” ๐—ฆ๐˜‚๐—ฏ๐˜€๐—ฐ๐—ฟ๐—ถ๐—ฝ๐˜๐—ถ๐—ผ๐—ป-๐—•๐—ฎ๐˜€๐—ฒ๐—ฑ ๐—Ÿ๐—ถ๐—ฏ๐—ฟ๐—ฎ๐—ฟ๐˜† (๐—ฃ๐—ฟ๐—ฒ๐—บ๐—ถ๐˜‚๐—บ ๐—ผ๐—ป-๐—ฑ๐—ฒ๐—บ๐—ฎ๐—ป๐—ฑ, ๐˜€๐˜‚๐—ฏ๐˜€๐—ฐ๐—ฟ๐—ถ๐—ฝ๐˜๐—ถ๐—ผ๐—ป-๐—ฏ๐—ฎ๐˜€๐—ฒ๐—ฑ ๐—ฝ๐—ฟ๐—ถ๐—ฐ๐—ถ๐—ป๐—ด ๐—บ๐—ผ๐—ฑ๐—ฒ๐—น) ๐—ข๐—ณ๐—ณ๐—ฒ๐—ฟ๐—ฒ๐—ฑ ๐—ฏ๐˜† ๐—”๐—น๐—น๐—ถ๐—ฒ๐—ฑ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

๐—ง๐—ฟ๐—ฒ๐—ป๐—ฑ๐—ถ๐—ป๐—ด ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜๐˜€ ๐—ถ๐—ป ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† (๐—•๐—ผ๐—ผ๐—ธ ๐—ก๐—ผ๐˜„ ๐˜„๐—ถ๐˜๐—ต ๐Ÿญ๐Ÿฌ% ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜‚๐—ป๐˜):

Vaccine Market โ€“ Opportunity & Industry Forecast, 2027
Insomnia Market โ€“ Opportunity & Industry Forecast, 2026

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn